InvestorPlace Earnings

InvestorPlace Earnings

InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

Recent Articles

POLA Stock Earnings: Polar Power Reported Results for Q2 2024

By InvestorPlace Earnings

Polar Power just reported results for the second quarter of 2024.

VYNE Stock Earnings: VYNE Therapeutics Misses EPS, Beats Revenue for Q2 2024

By InvestorPlace Earnings

VYNE stock results show that VYNE Therapeutics missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

RVPH Stock Earnings: Reviva Pharmaceuticals Beats EPS for Q2 2024

By InvestorPlace Earnings

RVPH stock results show that Reviva Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024.

MGX Stock Earnings: Metagenomi Beats EPS, Beats Revenue for Q2 2024

By InvestorPlace Earnings

MGX stock results show that Metagenomi beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

NRBO Stock Earnings: NeuroBo Pharmaceuticals Misses EPS for Q2 2024

By InvestorPlace Earnings

NRBO stock results show that NeuroBo Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024.

Load More